Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

bavituximab plus paclitaxel and carboplatin

Weekly bavituximab dose of 3 mg/kg until disease progression, and up to 6 cycles of carboplatin at a dose of AUC=5 and paclitaxel 175 mg/m2 every 21 days (21-day cycles)

Trial Locations (9)

560 076

Apollo Hospital, Bannerghatta Rd

560 027

Kidwai Hospital, Munigowda Road

Bangalore Institute of Oncology Speciality Centre, Sampangi Ram Nagar

560 054

M S Ramaiah Hospital, New BEL Rd

500 082

Nizam's Institute of Medical Sciences, Panjagutta

Yashoda Hospital, Somājigūda

695 011

RCC Medical College, Trivandrum

Unknown

Orchid Nursing Home, Phoolanbhaghan

411-001

Ruby Hall Clinic, Pune

Sponsors
All Listed Sponsors
lead

Peregrine Pharmaceuticals

INDUSTRY